Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | ANPEP | P15144 | 2/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 3/20 | 0.47 |
| ▸ | LAP3 | P28838 | 3/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8527002 | 1.00 | EPHX1 (0.59) | EPHX1ANPEPALPIPKMPTGS1 | |
| SCHEMBL27712365 | 1.00 | EPHX1 (0.59) | EPHX1ANPEPALPIPKMPTGS1 | |
| Hydrochloric Acid SCHEMBL29410716 | 0.98 | EPHX1 (0.57) | EPHX1ANPEPALPIPKMPTGS1 | |
| SCHEMBL8748122 | 0.83 | TAAR1 (0.50) | SLC7A5SLC6A2TAAR1 | |
| SCHEMBL18167808 | 0.82 | EPHX1 (0.61) | EPHX1ANPEPALPIPKMPTGS1 | |
| SCHEMBL18167806 | 0.82 | EPHX1 (0.61) | EPHX1ANPEPALPIPKMPTGS1 | |
| SCHEMBL27700316 | 0.81 | ANPEP (0.50) | EPHX1ANPEP | |
| SCHEMBL27720875 | 0.81 | EPHX1 (0.55) | EPHX1ANPEPALPIPKMPTGS1 | |
| SCHEMBL352772 | 0.81 | EPHX1 (0.55) | EPHX1ANPEPALPIPKMPTGS1 | |
| SCHEMBL27700318 | 0.81 | EPHX1 (0.55) | EPHX1ANPEPALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116875980-A | Copper-reducing additive for HDI board and copper-reducing process | 上海天承化学有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-114605976-A | Polysulfonic acid silane composite graphene oxide plugging agent and oil-based drilling fluid | 西南石油大学 | 2022-06-10 | — | — | CN | claimed |
| EP-0467856-B1 | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 1997-03-19 | — | — | EP | claimed |
| EP-0467856-A2 | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 1992-01-22 | — | — | EP | claimed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| CN-116875980-A | Copper-reducing additive for HDI board and copper-reducing process | 上海天承化学有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-116234802-A | Quinoline CGAS antagonist compounds | 免疫传感器治疗股份有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-114605976-A | Polysulfonic acid silane composite graphene oxide plugging agent and oil-based drilling fluid | 西南石油大学 | 2022-06-10 | — | — | CN | disclosed |
| CN-101851182-B | Salt-free preparation method for substituted taurine | UNIV BEIJING CHEMICAL | 2013-07-17 | — | — | CN | disclosed |
| CN-101337914-B | Preparation method of taurine and substituted taurine | UNIV BEIJING CHEMICAL | 2012-04-04 | — | — | CN | disclosed |
| CN-101255126-B | Preparation of taurine and derivatives thereof | UNIV BEIJING | 2010-12-01 | — | — | CN | disclosed |
| CN-101148427-B | Method for preparing substituted taurine | UNIV BEIJING | 2010-10-27 | — | — | CN | disclosed |
| US-20050038000-A1 | Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2005-02-17 | — | — | US | disclosed |
| WO-2005000406-A2 | TREATMENT OF AMYLOID- AND EPILEPTOGENESIS-ASSOCIATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-01-06 | — | — | WO | disclosed |
| CN-1369496-A | Use of compound with structure similar to L-phenylalanine as medicine to treat skin diseases | LU XIAODE (CN) | 2002-09-18 | — | — | CN | disclosed |
| EP-0460679-B1 | Endothelin antagonistic peptide derivatives | BANYU PHARMA CO LTD (JP) | 1998-10-28 | — | — | EP | disclosed |
| US-5691315-A | CARDIOVASCULAR DISORDERS; VASODILATOR; BRONCHODILATOR | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-11-25 | — | — | US | disclosed |
| US-5470833-A | Vasodilators, bronchodilators | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-11-28 | — | — | US | disclosed |
| US-5444152-A | Vasolidator or bronchodilator | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-08-22 | — | — | US | disclosed |
| EP-0460679-A2 | Endothelin antagonistic peptide derivatives | Banyu Pharmaceutical Co., Ltd. (JP) | 1991-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | EPHX1 3226/4885ANPEP 1189/4885ALPI 2273/4885 |
| US-20050038000-A1 | Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases | APP, PSEN1, PSEN2 | EPHX1 148/4885ANPEP 640/4885ALPI 1651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.